BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28432157)

  • 1. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Holte E; Kleveland O; Ueland T; Kunszt G; Bratlie M; Broch K; Michelsen AE; Bendz B; Amundsen BH; Aakhus S; Damås JK; Gullestad L; Aukrust P; Wiseth R
    Heart; 2017 Oct; 103(19):1521-1527. PubMed ID: 28432157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
    Kleveland O; Kunszt G; Bratlie M; Ueland T; Broch K; Holte E; Michelsen AE; Bendz B; Amundsen BH; Espevik T; Aakhus S; Damås JK; Aukrust P; Wiseth R; Gullestad L
    Eur Heart J; 2016 Aug; 37(30):2406-13. PubMed ID: 27161611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction.
    Helseth R; Kleveland O; Ueland T; Wiseth R; Damas JK; Broch K; Michelsen A; Bendz B; Gullestad L; Aukrust P; Seljeflot I
    Open Heart; 2021 May; 8(1):. PubMed ID: 33972404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction.
    Kleveland O; Ueland T; Kunszt G; Bratlie M; Yndestad A; Broch K; Holte E; Ryan L; Amundsen BH; Bendz B; Aakhus S; Espevik T; Halvorsen B; Mollnes TE; Wiseth R; Gullestad L; Aukrust P; Damås JK
    Int J Cardiol; 2018 Nov; 271():1-7. PubMed ID: 29961572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
    Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
    Front Immunol; 2018; 9():2035. PubMed ID: 30258440
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction.
    Ueland T; Kleveland O; Michelsen AE; Wiseth R; Damås JK; Holven KB; Aukrust P; Gullestad L; Yndestad A; Halvorsen B
    Int J Cardiol; 2019 Jan; 274():348-350. PubMed ID: 29961573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction.
    Montisci R; Chen L; Ruscazio M; Colonna P; Cadeddu C; Caiati C; Montisci M; Meloni L; Iliceto S
    Heart; 2006 Aug; 92(8):1113-8. PubMed ID: 16449513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.
    Ikonomidis I; Pavlidis G; Katsimbri P; Andreadou I; Triantafyllidi H; Tsoumani M; Varoudi M; Vlastos D; Makavos G; Kostelli G; Βenas D; Lekakis J; Parissis J; Boumpas D; Alexopoulos D; Iliodromitis E
    Clin Res Cardiol; 2019 Oct; 108(10):1093-1101. PubMed ID: 30859382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.
    Shah NR; Cheezum MK; Veeranna V; Horgan SJ; Taqueti VR; Murthy VL; Foster C; Hainer J; Daniels KM; Rivero J; Shah AM; Stone PH; Morrow DA; Steigner ML; Dorbala S; Blankstein R; Di Carli MF
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between left ventricular global and regional longitudinal systolic strain and impaired microcirculation in patients with acute myocardial infarction.
    Løgstrup BB; Høfsten DE; Christophersen TB; Møller JE; Bøtker HE; Pellikka PA; Egstrup K
    Echocardiography; 2012 Nov; 29(10):1181-90. PubMed ID: 22862151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction.
    Kitabata H; Imanishi T; Kubo T; Takarada S; Kashiwagi M; Matsumoto H; Tsujioka H; Ikejima H; Arita Y; Okochi K; Kuroi A; Ueno S; Kataiwa H; Tanimoto T; Yamano T; Hirata K; Nakamura N; Tanaka A; Mizukoshi M; Akasaka T
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):263-72. PubMed ID: 19356570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X.
    Galiuto L; Sestito A; Barchetta S; Sgueglia GA; Infusino F; La Rosa C; Lanza G; Crea F
    Am J Cardiol; 2007 May; 99(10):1378-83. PubMed ID: 17493464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of infarct size using transthoracic Doppler echocardiographic measurement of coronary flow reserve in infarct related and reference coronary artery.
    Giga V; Dobric M; Beleslin B; Sobic-Saranovic D; Tesic M; Djordjevic-Dikic A; Stepanovic J; Nedeljkovic I; Artiko V; Obradovic V; Seferovic PM; Ostojic M
    Int J Cardiol; 2013 Sep; 168(1):169-75. PubMed ID: 23058345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction.
    Løgstrup BB; Høfsten DE; Christophersen TB; Møller JE; Bjerre M; Flyvbjerg A; Bøtker HE; Egstrup K
    Coron Artery Dis; 2013 Sep; 24(6):487-92. PubMed ID: 23777975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Coronary Blood Flow After Acute Myocardial Infarction: Insights From a Patient Study and an Experimental Porcine Model.
    de Waard GA; Hollander MR; Teunissen PF; Jansen MF; Eerenberg ES; Beek AM; Marques KM; van de Ven PM; Garrelds IM; Danser AH; Duncker DJ; van Royen N
    JACC Cardiovasc Interv; 2016 Mar; 9(6):602-13. PubMed ID: 27013161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
    George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
    J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
    Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
    Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early assessment of coronary flow reserve by transthoracic Doppler echocardiography predicts late remodeling in reperfused anterior myocardial infarction.
    Rigo F; Varga Z; Di Pede F; Grassi G; Turiano G; Zuin G; Coli U; Raviele A; Picano E
    J Am Soc Echocardiogr; 2004 Jul; 17(7):750-5. PubMed ID: 15220900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab.
    Woxholt S; Ueland T; Aukrust P; Anstensrud AK; Broch K; Tøllefsen IM; Ryan L; Bendz B; Hopp E; Kløw NE; Seljeflot I; Halvorsen B; Dahl TB; Huse C; Andersen GØ; Gullestad L; Wiseth R; Amundsen BH; Damas JK; Kleveland O
    Open Heart; 2023 Aug; 10(2):. PubMed ID: 37591633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial.
    Huse C; Anstensrud AK; Michelsen AE; Ueland T; Broch K; Woxholt S; Yang K; Sharma K; Tøllefsen IM; Bendz B; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Quiles-Jiménez A; Bjerkeli V; Bendz C; Kleveland O; Stensaeth KH; Opdahl A; Kløw NE; Andersen GØ; Wiseth R; Halvorsen B; Gullestad L; Seljeflot I; Aukrust P; Osnes L; Dahl TB
    EBioMedicine; 2022 Jun; 80():104013. PubMed ID: 35504178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.